Company-level financial information
UNITEDHEALTH GROUP INC
Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.
Annual net income
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 19,697.0 | SEC filingMar 2, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 12,056.0 | SEC filingMar 2, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Common-stock cash dividends | 7,916.0 | SEC filingMar 2, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 3,622.0 | SEC filingMar 2, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 24,204.0 | SEC filingMar 2, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 14,405.0 | SEC filingMar 2, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Common-stock cash dividends | 7,533.0 | SEC filingMar 2, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 3,499.0 | SEC filingMar 2, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 29,068.0 | SEC filingMar 2, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | 22,381.0 | SEC filingMar 2, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Common-stock cash dividends | 6,761.0 | SEC filingMar 2, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 3,386.0 | SEC filingMar 2, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 26,206.0 | SEC filingFeb 27, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | 20,120.0 | SEC filingFeb 27, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Common-stock cash dividends | 5,991.0 | SEC filingFeb 27, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 2,802.0 | SEC filingFeb 27, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Operating cash flow | 22,343.0 | SEC filingFeb 28, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 17,285.0 | SEC filingFeb 28, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Common-stock cash dividends | 5,280.0 | SEC filingFeb 28, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 2,454.0 | SEC filingFeb 28, 2024 |
| Dec 31, 2020From Jan 1, 2020 | Operating cash flow | 22,174.0 | SEC filingFeb 24, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Net income | 15,403.0 | SEC filingFeb 24, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Common-stock cash dividends | 4,584.0 | SEC filingFeb 24, 2023 |
| Dec 31, 2020From Jan 1, 2020 | Capital expenditures (PP&E) | 2,051.0 | SEC filingFeb 24, 2023 |
| Dec 31, 2019From Jan 1, 2019 | Operating cash flow | 18,463.0 | SEC filingFeb 15, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Net income | 13,839.0 | SEC filingFeb 15, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Common-stock cash dividends | 3,932.0 | SEC filingFeb 15, 2022 |
| Dec 31, 2019From Jan 1, 2019 | Capital expenditures (PP&E) | 2,071.0 | SEC filingFeb 15, 2022 |